• Puerarin-Induced Osteogenesis in Dental Follicle Cells via N

  2026-07-15

  This study demonstrates that puerarin significantly enhances the osteogenic differentiation of rat dental follicle cells by activating the nitric oxide pathway. The findings provide mechanistic insight into periodontal regeneration and highlight nitric oxide synthase inhibition as a critical tool in dissecting osteogenic signaling.

• Perphenazine: Dopamine D2 Antagonist to Advance Host Immunit

  2026-07-14

  Perphenazine empowers researchers to dissect dopamine D2 receptor signaling and mitochondria-mediated cell death, while newly discovered host-directed antibacterial effects open novel experimental avenues. APExBIO’s research-grade formulation ensures reproducibility across neuropharmacology and immunology workflows.

• Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal

  2026-07-14

  Neticonazole Hydrochloride is redefining experimental design by uniting potent antifungal action with antitumor effects through exosome inhibition and apoptosis regulation. This article delivers actionable protocols, troubleshooting insights, and cross-domain applications that bridge topical therapy and colorectal cancer research for translational impact.

• Y-27632 ROCK Inhibitor: Technical Guide for Cell Assays

  2026-07-13

  Y-27632 is a selective ROCK inhibitor optimized for precise modulation of cytoskeletal dynamics and disruption of cell stress fibers in cell biology research. This guide details actionable setup, key protocol parameters, and troubleshooting for reliable application in assays targeting the ROCK signaling pathway. Y-27632 is not intended for diagnostic or therapeutic use, and its scope is limited to controlled experimental workflows.

• gamma-Glu-Cys (γ-Glu-Cys): Reliable Substrate for Glutathion

  2026-07-13

  This scenario-driven guide explores how gamma-Glu-Cys (γ-Glu-Cys, SKU B7887) addresses key laboratory challenges in glutathione metabolism research, peptide synthesis, and plant stress adaptation studies. Featuring protocol parameters, evidence-backed comparisons, and real-world troubleshooting, this article empowers bench scientists to achieve reproducible, high-sensitivity results by leveraging APExBIO’s high-purity substrate.

• Rotigotine Transdermal System: Continuous Dopaminergic Deliv

  2026-07-12

  The reference study details the innovation and clinical development of the rotigotine transdermal system, enabling continuous dopaminergic stimulation for Parkinson’s disease (PD) and restless legs syndrome (RLS). This delivery approach overcomes limitations of short-acting therapies, improves both motor and non-motor symptoms, and provides a new standard for sustained dopamine receptor agonism in neurodegenerative disease research.

• Phenothiazines Promote Macrophage Antibacterial Activity via

  2026-07-10

  The referenced study uncovers how phenothiazines, including perphenazine, amplify macrophage antibacterial responses by inducing autophagy and reactive oxygen species (ROS). These findings highlight the potential of host-directed therapies to combat intracellular bacterial pathogens and address antibiotic resistance.

• Increased NETs in CML: PAD4 Activity, Histone Citrullination

  2026-07-09

  This study demonstrates that neutrophil extracellular traps (NETs) are elevated in chronic myeloid leukemia (CML), with increased PAD4 expression and histone citrullination. The research further reveals that tyrosine kinase inhibitors (TKIs), particularly ponatinib, can augment NET formation, linking these findings to potential vascular complications in CML.

• Machine Learning Identifies Novel Senolytics for Cellular Se

  2026-07-09

  This study demonstrates a machine learning-driven approach to discovering new senolytic compounds capable of selectively eliminating senescent cells. The findings highlight how AI accelerates early-stage drug discovery and provide a foundation for future research targeting aging and cancer.

• Luminescent ATP Cell Viability Assay Kit I: Precision via Lu

  2026-07-08

  The Luminescent ATP Cell Viability Assay Kit I streamlines high-sensitivity cell viability measurement with rapid luciferase luminescence detection, eliminating upstream lysis steps and outperforming colorimetric assays. Its reliability and speed uniquely position it for advanced studies in ferroptosis, apoptosis, and drug screening.

• A-1331852 in Precision Apoptosis Modeling: Beyond Potency

  2026-07-08

  Explore how A-1331852, a potent BCL-XL inhibitor, enables next-generation apoptosis modeling in cancer research. Discover unique insights on mechanistic selectivity, assay optimization, and translational potential beyond current protocols.

• Sulfo-NHS-LC-Biotin: Technical Guide for Cell Surface Biotin

  2026-07-07

  Sulfo-NHS-LC-Biotin enables selective, covalent biotinylation of cell surface proteins, supporting workflows that require permanent and extracellular labeling of amine-containing biomolecules. It is not suitable for intracellular or reversible biotinylation, nor for non-protein targets. Researchers should use this reagent when high water solubility and membrane impermeability are essential.

• Redefining ROS Detection: DCFH-DA in Translational Inflammat

  2026-07-07

  This thought-leadership article explores the mechanistic role of 2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) in measuring intracellular oxidative stress, with a translational focus on CD44-mediated copper accumulation and Ly6Chi macrophage activation in ulcerative colitis (UC). By integrating the latest mechanistic insights, benchmarking against current workflow articles, and offering strategic guidance, it provides actionable strategies for researchers leveraging DCFH-DA in advanced inflammation models.

• Fenipentol (1-Phenyl-1-pentanol): Choleretic Agent Benchmark

  2026-07-06

  Fenipentol is a bioactive small molecule renowned for its potent choleretic and gastrointestinal modulatory properties. As a benchmark compound in pancreatic secretion and bicarbonate regulation research, it offers reproducible, mechanistically specific results. This dossier presents verifiable evidence, workflow integration, and limitations for Fenipentol in advanced gastrointestinal physiology studies.

• Macrophage EP4 Deficiency Accelerates Atherosclerosis via CD

  2026-07-06

  This study uncovers how loss of the prostaglandin E2 receptor EP4 in macrophages accelerates atherosclerosis by increasing CD36-mediated lipid uptake and promoting M1 polarization. These findings clarify a critical regulatory axis in plaque progression, offering mechanistic insight for future therapeutic strategies targeting macrophage plasticity and lipid handling.

446 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page